Search PubMed⌕ Search

Biomedical subjects

M Wilkinson

Publications and source records attributed to M Wilkinson.

At least 127 records · Page 7Linked to original sources

A comparison of chamba (marijuana) abusers and general psychiatric admissions in Malawi.

The study aimed to provide the first general description of chamba-related admissions to Zomba Mental Hospital, the major psychiatric facility in Malawi, and to analyse the distinctiveness of this patient group from other admissions. A questionnaire was verbally administered to 50 chamba abusers and 50 other patients matched by gender, age, and admission date. The typical chamba abusing patient is: 27, male, a subsistence farmer, takes the drug because it is the cheapest form of intoxication, reports 'seeing things clearly' (immediate effect), and general apathy (long-term); and compared to other patients is more likely to originate from a chamba-growing area, less likely to have been raised by his natural parents, and has had more schooling.

Adolescent↗

Primary osteogenic sarcoma of the urinary bladder successfully treated with combination therapy.

A 54-year-old woman presented with a large bladder mass and left hydroureteronephrosis. At radical cystectomy (with ileal loop urinary diversion), an unresectable left obturator mass was found. Combination chemotherapy postoperatively resulted in significant shrinkage, and she underwent excision of the residual mass. No residual cancer was seen. The patient remains free of disease 56 months after cystectomy and 51 months after resection of the residual mass. Primary osteogenic sarcoma of the urinary bladder may respond to combination chemotherapy and surgery. All patients found to have advanced disease should be considered for this approach.

Antineoplastic Combined Chemotherapy Protocols↗

Audit of procedures related to outcome of chest clinic consultation.

We audited the case records of 493 new patients referred to a chest clinic to determine for eight consultants and five middle-grade staff the average number of investigations performed, the follow-up rate and prolixity (the length of the letter written to the general practitioner). The outcome of the consultation was assessed by a questionnaire administered to the patients' general practitioners. Practitioner mean investigation rates varied from 0.1 to 8.7 investigations per patient, follow-up rate from 45 to 100% and average prolixity from 53 to 200mm. The prolixity of the eight consultants was significantly related to their investigation and follow-up rates. Consultation outcome was at least satisfactory for 97.4% of patients. We conclude that considerable potential exists for savings of laboratory, clinic and secretarial time and costs by reducing investigation and follow-up rates and writing shorter letters to general practitioners.

Family Practice↗

Minimal modification of canine ventricular myocyte cell surface beta adrenoceptors despite desensitisation of ventricular function during exogenous beta adrenoceptor challenge.

OBJECTIVE: The aim was to determine whether a 120 min exposure of ventricular myocytes to beta agonist challenge alters ventricular cell surface beta adrenergic receptors concomitant with desensitisation of ventricular function. METHODS: Supramaximal doses of isoprenaline (1 microgram.kg-1.min-1 intravenously) were given continuously to anaesthetised dogs for 15 (n = 6), 60 (n = 2), and 120 (n = 6) min. Changes induced during beta adrenoceptor challenge in right and left ventricular systolic pressures were correlated with right and left ventricular myocyte beta adrenoceptor number and affinity. RESULTS: Isoprenaline initiated early augmentation in right [23(SEM 3)-78(10) mm Hg] and left [82(6)-186(11) mm Hg] ventricular intramyocardial systolic pressures. After 5 min of continuous exogenous beta agonist challenge these pressures were reduced to 42(4) mm Hg and 104(16) mm Hg, respectively, even though the agonist challenge persisted. Throughout the subsequent 115 min exposure period these pressures remained relatively similar. Despite these inotropic effects the number (Bmax) and affinity (Kd) of ventricular myocyte beta adrenergic cell surface receptors, as determined by the tissue slice technique, were similar before and after 15, 60, and 120 min exposure to isoprenaline. CONCLUSIONS: (1) After the desensitisation of the initial enhancement of ventricular inotropism that occurs during the first 5 min of a beta agonist challenge, inotropism remains relatively constant for the next 115 min exposure. (2) Desensitisation of ventricular inotropism elicited during 2 h exposure of the in situ heart to a beta agonist challenge is not primarily due to altered myocyte cell surface beta adrenergic receptor number or affinity.

Animals↗

A critical period for glutamate receptor-mediated induction of precocious puberty in female rats.

The excitatory amino acid glutamate and especially its NMDA subtype receptor are important components of the neural system that regulates sexual maturation. It is known that multiple daily injections of immature rats and monkeys with NMDA will induce precocious puberty. We have previously reported that a single daily injection of NMDA administered from 27 days of age to the day of vaginal opening (VO) is sufficient to synchronize and slightly accelerate (1-2 days) first ovulation in female rats. We have now optimized this treatment schedule and show that a higher dose of NMDA (20 mg/kg), or the racemic mixture N-methyl-D,L-aspartate (NMA; 30 mg/kg), initiated earlier in development (24 days to VO) significantly advances first ovulation (4 days). Rats induced to ovulate prematurely had normal estrous cycles. We also report that the same degree of precocity can be obtained when injections are discontinued well before first ovulation occurs. For example, NMA administered from day 21 to 25 or from day 24 to 28 accelerates sexual maturation to the same degree as if injections were continued until VO was observed. It is clear that the hypothalamic-pituitary-ovarian (H-P-O) axis is stimulated by daily NMDA treatment as shown by the dose-related luteinizing hormone (LH) release and by an estrogen-dependent rise in uterine weight. However, stimulation of the P-O axis with daily injections of GnRH (5 ng/100 g), which elicits an LH response slightly greater than NMDA (20 mg/kg), does not advance puberty. This suggests that NMDA induces some change in hypothalamic control which is not directly related to LH secretion. Interestingly, there also seems to be a critical period of NMDA effectiveness because daily injections of NMA (30 mg/kg) from day 16 to 20 do not induce precocious puberty. Since the ovaries respond with increased estrogen production (increased uterine weight) to gonadotrophin stimulation at this early age (16 days) we conclude that the hypothalamus may be relatively unresponsive to stimulation with NMDA. Paradoxically the hypothalamus is also hyporesponsive to NMDA in the period preceding spontaneous first ovulation. We now show that an LH dose-response curve for NMDA at age 28 days demonstrates that in NMDA-treated rats the LH response to NMDA is less than in the control group. Further, the hyporesponsiveness is not due to pituitary desensitization since an LH dose-response curve for GnRH at age 28 days is identical in the NMDA-treated and control groups.(ABSTRACT TRUNCATED AT 400 WORDS)

Animals↗

Migraine treatment: the British perspective.

Migraine occurs in about 10% of the population in the United States and the United Kingdom. In the United States there seem to be more complicated patients and the expectations of the patient are higher. In the United Kingdom there is a tendency to use single rather than compound formulations, and drugs such as barbiturates cannot be prescribed for migraine. In treating migraine the first and most important thing is to get the correct diagnosis which depends on the history and the absence of abnormal physical signs. Investigations do not confirm the diagnosis of migraine, they are only necessary to exclude other causes of headaches. Most sufferers from migraine have less than four attacks a month. Attack therapy is usually all that is required, and over the past 20 years efficient attack therapy has been developed. This depends mainly on sleep, an antinauseant, analgesics, ergotamine and more recently sumatriptan.

Acute Disease↗

The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision.

BACKGROUND: We have previously demonstrated that the minimum alveolar concentration of isoflurane at 1 atm that is required to prevent movement in 50% of patients or animals exposed to a maximal noxious stimulus is markedly reduced by increasing fentanyl concentrations. Total intravenous anesthesia with propofol is increasing in popularity, yet the propofol concentrations required for total intravenous anesthesia or the interaction between propofol and fentanyl have not yet been defined. METHODS: Propofol and fentanyl were administered via computer-assisted continuous infusion to provide pseudo-steady-state concentrations and allow equilibration between plasma-blood concentration and their biophase concentration. For the induction of anesthesia patients were randomly allocated to receive propofol only or propofol plus fentanyl 0.2, 0.8, 1.5, 3.0, and 4.5 ng/ml. In each group patients were randomized to target propofol concentrations of 1.5-10 micrograms/ml. At 7 and 10 min arterial blood samples were taken for subsequent measurement of propofol and fentanyl concentrations. At 10 min loss of consciousness was assessed by the patients' ability to respond to a simple verbal command. Thereafter a new target concentration of propofol was entered to ensure loss of consciousness, and succinylcholine was administered to facilitate tracheal intubation. Patients were rerandomized to a new target concentration of propofol (1-19 micrograms/ml) until skin incision. Before skin incision and 1 min after skin incision, arterial blood samples were again obtained for subsequent measurement of fentanyl and propofol concentrations. At skin incision and for 1 min the patient was observed for purposeful movement. Only samples in which the pre- and poststimulus drug concentrations were within 35% of each other were included. The propofol blood concentration at which 50% or 95% of patients did not respond to verbal command (Cp50s and Cp95s, respectively) and to skin incision (Cp50i and Cp95i, respectively), were calculated by logistic regression. RESULTS: There were 56 evaluable patients for calculating the propofol Cp50s and 53 patients for calculating the propofol Cp50i. For propofol alone the Cp50s was 3.3 micrograms/ml and the Cp95s 5.4 microgram/ml. Increasing fentanyl concentrations reduced the Cp50s (P = 0.03), and increasing age decreased the Cp50s (P = 0.04). For propofol alone the Cp50i was 15.2 (95% confidence interval 7.6-22.8) micrograms/ml and the Cp95i 27.4 micrograms/ml. Increasing fentanyl concentrations markedly reduced the Cp50i (P < 0.01), with a 50% reduction in Cp50i produced by 0.63 ng/ml fentanyl. The propofol Cp50i was decreased by 63% with 1 ng/ml fentanyl and 89% by 3 ng/ml fentanyl. At higher fentanyl concentrations the decrease in Cp50i was proportionally less, demonstrating a ceiling effect. CONCLUSIONS: We defined the propofol concentration required for loss of consciousness and showed that it is reduced by increasing fentanyl concentration and by increasing age. The propofol concentration (alone) adequate for skin incision is high but is markedly reduced by fentanyl. A ceiling effect in the Cp50i for propofol is seen with fentanyl concentrations greater than 3 ng/ml.

Adult↗

Patient weights: from physician complaints to improved nursing practice through quality improvement.

Identification of a patient-centered problem led the Quality Improvement Committee to the development of a standard of care and a concurrent clinical monitor. This project focused on nurses making an assessment when a patient's daily weight fluctuated more than 1 kg. Although the problem was patient oriented, the indicators of the concurrent monitor reviewed the nursing practice.

Humans↗

Detection of Chlamydia trachomatis in general practice urine samples.

BACKGROUND: Chlamydia trachomatis is frequently overlooked as a cause of dysuria and urinary frequency in general practice patients. AIM: This study set out to determine the impact of performing chlamydial antigen detection on sterile pyuria samples from patients aged 16-65 years and which were submitted to a hospital microbiology laboratory by general practitioners in the Winchester health district for routine microbiological investigations. METHOD: Chlamydial antigen detection was performed by enzyme immunoassay and direct immunofluorescence. The cost of performing the test was estimated. In the first year of the study (1991) questionnaires were sent to general practitioners whose patients had a positive test result. RESULTS: A total of 1025 samples of sterile pyuria were received at the laboratory between January 1991 and March 1993. Chlamydial antigen was detected in 54 samples (5%); 22 men and 32 women aged between 16 and 57 years (mean 25 years). The detection rate was highest in the 16-20 years age group (22% of men had a positive sample and 7% of women). Completed questionnaires from 27 general practitioners revealed that 59% of their patients were referred to the genitourinary clinic for treatment and contact tracing. The others were treated by the general practitioner. The cost of the screening programme per cure in this population was estimated to be 246 pounds. CONCLUSION: C trachomatis is a significant pathogen which may go unrecognized and untreated. The cost, medically and financially, of screening for this pathogen and treating infected patients and contacts is likely to be less than ignoring it, particularly if screening is confined to the 16-30 years age group. General practitioners should consider the diagnosis of chlamydial infection in young adult patients with sterile pyuria, and microbiology laboratories should screen sterile pyuria samples for chlamydial antigen.

Adolescent↗

Anomalous adrenalectomy-induced Fos-like immunoreactivity in the hypothalamic paraventricular nucleus of stress-hyporesponsive rats.

Cellular activity in the paraventricular nucleus of the hypothalamus (PVN) in response to adrenalectomy (ADX) and sham-ADX was measured in adult male rats, lactating females, and nursing pups using c-fos immunocytochemistry. Increased Fos-like immunoreactivity (FLI) was seen in the PVN of male rats at 4 h following ADX or sham-ADX but this increase was transient, and basal values were restored within 24 h. In suckling pups, ADX induced a marked FLI response in the PVN at 3 days and at 18 days postpartum. At 11 days postpartum, however, the FLI response was attenuated relative to adult animals, and 3- and 18-day-old pups. Similarly, in nursing mothers, ADX induced FLI at 3 days, but this response disappeared by 7 days and did not reappear by the end of the suckling period (day 21). These data indicate that c-fos expression is a sensitive indicator of hyporesponsiveness in the hypothalamic-pituitary-adrenal (HPA) system.

Adrenal Glands↗

Yang et al. reply.

Explore the source record for details and available documents.

Journal Article↗

Odor-induced sexual maturation and expression of c-fos in the olfactory system of juvenile female mice.

Exposure to the urine or soiled bedding odors of novel adult males is known to accelerate puberty in juvenile female mice. To determine what part of the olfactory system is activated by these odors, the expression of c-fos in the main olfactory bulb (MOB) and the accessory olfactory bulb (AOB) of juvenile female mice was examined after their exposure to male-soiled bedding, peppermint odor or their own bedding. Fos-like immunoreactivity was found throughout the AOB of the juvenile female mice exposed to the bedding odors of adult males for 3 h. In contrast, dense staining was found in the granular cell layer of the MOB of mice exposed to peppermint odors for 3 h, whereas mice exposed to their own bedding failed to show immunostaining in the AOB and only slight or no staining in the MOB. These results indicate that social odors stimulate the expression of c-fos in the AOB while non-social odors activate the MOB. This method allows the identification of individual cells activated by the different odors and will be useful in locating other areas of the brain involved in the neuroendocrine changes underlying odor-induced precocious puberty.

Animals↗

Age- and dose-related NMDA induction of Fos-like immunoreactivity and c-fos mRNA in the arcuate nucleus of immature female rats.

Glutamate and the N-methyl-D-aspartate (NMDA) receptor are important regulatory components of the hypothalamic control of luteinizing hormone (LH) secretion. Peripheral injection of prepubertal rats with NMDA induces maximal secretion of LH within 8 min as well as the expression of the proto-oncogene, c-fos, within the mediobasal hypothalamus (MBH). Because the induction of the c-fos gene is recognized as a sensitive marker of neuronal activity, the detection and characterization of c-fos mRNA and Fos protein may be particularly useful in the analysis of the GnRH (gonadotropin releasing hormone) neuronal system. This study has examined the effect of different doses of NMDA on c-fos mRNA and Fos-like immunoreactivity (Fos-lir); the time-course of induction of c-fos mRNA and the appearance of Fos-lir expression and the ontogeny of NMDA-induced Fos-lir. Our results indicate that NMDA-induced c-fos mRNA and protein are maximal by 60 and 120 min, respectively. Both c-fos mRNA and protein attain peak levels using NMDA doses between 20 and 40 mg/kg. Ontological studies demonstrated that Fos-lir could be detected at 5 days after birth, but declined after sexual maturation. The data presented here indicate that the immunohistochemical localization of c-fos gene expression, in conjunction with in situ hybridization, is a useful technique for mapping NMDA-sensitive pathways and may provide anatomical and physiological evidence that better defines the glutamatergic control of sexual maturation.

Aging↗

Identification of Exo2 as the catalytic subunit of protein kinase A reveals a role for cyclic AMP in Ca(2+)-dependent exocytosis in chromaffin cells.

Digitonin-permeabilized chromaffin cells secrete catecholamines by exocytosis in response to micromolar Ca2+ concentrations, but lose the ability to secrete in response to Ca2+ as the cells lose soluble proteins through the plasma membrane pores. We have previously shown [Morgan and Burgoyne (1992) Nature, 355, 833-836] that cytosol can retard this loss of secretory competence and that two distinct stimulatory activities (Exo1 and Exo2) are present in cytosol. Here we report that Exo2 behaved as a single peak of activity through purification on hydroxyapatite, ammonium sulfate precipitation and gel filtration and the activity correlated with a single polypeptide of approximately 44 kDa on SDS gels. Protein sequencing of this band revealed it to be the catalytic subunit of cyclic AMP-dependent protein kinase (PKA). Both cyclic AMP and the commercially available catalytic subunit of PKA stimulated exocytosis in a dose-dependent manner which was absolutely dependent on the presence of micromolar Ca2+. These data show that PKA (Exo2) regulates Ca(2+)-dependent exocytosis in bovine adrenal chromaffin cells.

Amino Acid Sequence↗

Domperidone plus paracetamol in the treatment of migraine.

This study was designed to evaluate the safety and efficacy of domperidone in combination with paracetamol in the treatment of migraine. Severity of headache, duration of migraine attack and overall efficacy of treatment were amongst the variables assessed in a randomized, double-blind, three-way cross-over comparison of 1 g paracetamol plus either domperidone 30 mg, domperidone 20 mg or placebo, taken at onset of headache. Forty-six patients attending the City of London Migraine Clinic completed the study. A significant difference was observed in the duration of the migraine attack: a median of 17.5 h with paracetamol alone was reduced to 12.0 h with the addition of domperidone 20 mg, and to 12.0 h with domperidone 30 mg. No significant adverse events were reported. A reduction in pain intensity and nausea was noted but this was not statistically significant. It was concluded that domperidone shortens the duration of a migraine attack and may help reduce headache and associated symptoms.

Acetaminophen↗